Home Antibody All anti-MARK1 antibodies
Also for MARK1 (NM_018650)
|The antiserum was produced against synthesized non-phosphopeptide derived from human MARK1/2/3/4 around the phosphorylation site of threonine 215 (L-D-TP-F-C)|
|Human, Mouse, Rat
|WB, IHC, IF
||WB: 1:500~1:3000, IHC: 1:50~1:100, IF: 1:100~1:500, ELISA: 1:1000
|Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.|
|The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
|MARK1/2/3/4 (Ab-215) antibody detects endogenous levels of total MARK1/2/3/4 protein.
|Homo sapiens MAP/microtubule affinity-regulating kinase 1 (MARK1), transcript variant 2|
|MARK; Par-1c; Par1c|
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis of extracts from COS-7 cells, using MARK1/2/3/4 (Ab-215) antibody.The lane on the right is treated with the synthesized peptide.
Immunohistochemistry analysis of paraffin-embedded human breast carcinoma tissue using MARK1/2/3/4 (Ab-215) antibody.The picture on the right is treated with the synthesized peptide.
Immunofluorescence analysis of HeLa cells, using MARK1/2/3/4 (Ab-215) antibody.The picture on the right is treated with the synthesized peptide.